Abstract
This chapter focuses on benzoxazoles. It makes use of one US patent throughout the text to discuss benzoxazoles. The assignee for the patent is Euro-Celtique, S.A. The chapter also mentions the utility designation for this patent and that is phosphodiesterases (pdes) inhibitor for treating asthma. The reader can get a better understanding of the subject by going through the reactions mentioned afterwards. Further, the experimental section outlines detailed step-by-step procedure to explain it further. It is followed by notes that present further information on the experimental details mentioned. The reader is also provided with a few references to relevant prior art US patents that have been referred while collecting information for the content of this chapter.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Advances in Synthetic Organic Chemistry and Methods Reported in US Patents
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
